Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer

Mortazavi, M; Moosavi, F; Martini, M; Giovannetti, E; Firuzi, O

Firuzi, O (通讯作者),Shiraz Univ Med Sci, Med & Nat Prod Chem Res Ctr, Shiraz, Iran.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 176 ():

Abstract

Pancreatic ductal adenocarcinoma (PDAC) has one of the worst prognoses among all malignancies. PI3K/AKT/ mTOR signaling pathway, a main downstream eff......

Full Text Link